Scott Aaronson

Scott Aaronson

Auto-generated profile, based on publicly available information

Scott Aaronson

Department of Computer Science, The University of Texas at Austin, Austin, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
HSHarold A. Sackeim
Harold A. Sackeim
ARA. John Rush
A. John Rush
TGTeresa Greco
Teresa Greco
MJMei Jiang
Mei Jiang
SBSarah Badejo
Sarah Badejo
RMR. Hamish McAllister-Williams
R. Hamish McAllister-Williams
Background: In difficult-to-treat depression (DTD) the outcome metrics historically used to evaluate treatment effectiveness may be suboptimal. Metrics based on remission status and on single end-point (SEP) assessment may be problematic given infrequent symptom remission, temporal instability, and poor durability of benefit in DTD.Methods: Self-report and clinician assessment of depression symptom severity were regularly obtained over a 2-year period in a chronic and highly treatment-resistant registry sample (N = 406) receiving treatment as usual, with or without vagus nerve stimulation. Twenty alternative metrics for characterizing symptomatic improvement were evaluated, contrasting SEP metrics with integrative (INT) metrics that aggregated information over time. Metrics were compared in effect size and discriminating power when contrasting groups that did (N = 153) and did not (N = 253) achieve a threshold level of improvement in end-point quality-of-life (QoL) scores, and in their association with continuous QoL scores.Results: Metrics based on remission status had smaller effect size and poorer discrimination of the binary QoL outcome and weaker associations with the continuous end-point QoL scores than metrics based on partial response or response. The metrics with the strongest performance characteristics were the SEP measure of percentage change in symptom severity and the INT metric quantifying the proportion of the observation period in partial response or better. Both metrics contributed independent variance when predicting end-point QoL scores.Conclusions: Revision is needed in the metrics used to quantify symptomatic change in DTD with consideration of INT time-based measures as primary or secondary outcomes. Metrics based on remission status may not be useful.

20 January 2026 in Quantum Machine Intelligence
Verified
Journal Article
Closed access
PDF file
SAScott Aaronson
Scott Aaronson
ACAndrew M. Childs
Andrew M. Childs
EFEdward Farhi
Edward Farhi
AHAram W. Harrow
Aram W. Harrow
BSBarry C. Sanders
Barry C. Sanders

30 December 2021 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
ACA. Cutler
A. Cutler
SAS. Aaronson
S. Aaronson
GMGreg Mattingly
Greg Mattingly
SWS. Wilkinson
S. Wilkinson
RLR. Lasser
R. Lasser
SKS. Kanes
S. Kanes

24 June 2025 in arXiv
Verified
Preprint
Open access
PDF file
SAScott Aaronson
Scott Aaronson
ACAndrew M. Childs
Andrew M. Childs
EFEdward Farhi
Edward Farhi
AHAram W. Harrow
Aram W. Harrow
BSBarry C. Sanders
Barry C. Sanders
On Tuesday 26th November 2024, four discussants participated in a moderated virtual panel titled Future of Quantum Computing as one session of the 8th International Conference on Quantum Techniques in Machine Learning hosted by the University of Melbourne. This article provides a detailed summary of the discussion in this lively session.